A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1. BUSINESS We are a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, and patient monitors. Powered by the Masimo Hospital Automation™ and Masimo SafetyNet® platforms, Masimo connectivity, automation, and telehealth and telemonitoring solutions are improving and automating care delivery in the hospital. Our healthcare business develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation® and connectivity solutions, and remote monitoring devices. Our healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables.
| Metric | TTM | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.5B | 1.5B | 1.4B | 1.3B | 2.0B | 1.1B |
| Net Income | -152M | -152M | -305M | 82M | 144M | 240M |
| EPS | $-2.80 | $-2.80 | $-5.60 | $1.51 | $2.60 | $4.14 |
| Free Cash Flow | 198M | 198M | 175M | 56M | -23M | 139M |
| ROIC | - | - | -15.2% | 7.4% | 10.5% | 29.7% |
| Gross Margin | 61.9% | 61.9% | 56.9% | 60.0% | 52.0% | 65.0% |
| Debt/Equity | 0.00 | - | 0.72 | 0.71 | 0.77 | 0.22 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 310M | 310M | -267M | 166M | 210M | 256M |
| Operating Margin | 20.3% | 20.3% | -19.1% | 13.0% | 10.3% | 22.4% |
| ROE | 0.0% | - | -25.2% | 6.0% | 9.9% | 16.2% |
| Shares Outstanding | 54M | 54M | 54M | 54M | 55M | 58M |
MASIMO CORP passes 4 of 9 quality checks, suggesting mixed fundamentals.
On a free-cash-flow basis, the stock trades at 46.9x vs a median of 38.5x. The company's 5-year average ROIC is 8.1% with a gross margin of 59.2%. Total shareholder yield (buybacks) is 3.8%. At current prices, the estimated annualized return to fair value is -1.0%.
MASIMO CORP (MASI) has a 5-year average return on invested capital (ROIC) of 8.1%. This is below average and may indicate limited pricing power.
MASIMO CORP (MASI) has a market capitalization of $9.7B. It is classified as a mid-cap stock.
MASIMO CORP (MASI) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 3.77%.
MASIMO CORP (MASI) operates in the Electromedical & Electrotherapeutic Apparatus industry, within the Healthcare sector.
MASIMO CORP (MASI) reported annual revenue of $1.5 billion in its most recent fiscal year, based on SEC EDGAR filings.
MASIMO CORP (MASI) has a net profit margin of -9.9%. The company is currently unprofitable.
MASIMO CORP (MASI) generated $198 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
MASIMO CORP (MASI) reported earnings per share (EPS) of $-2.80 in its most recent fiscal year.
MASIMO CORP (MASI) has a 5-year average gross margin of 59.2%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for MASIMO CORP (MASI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
No recent press releases.